pfizer vaccine news - Search News

Pfizer, COVID-19

Reuters on MSN · 1d

Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London in September 2022,

National Post · 1d

Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

The Independent Singapore · 1d

HSA approves Pfizer’s new RSV vaccine

This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical protection to infants and seniors

Global News · 2d

Pfizer’s updated COVID-19 vaccine approved by Health Canada

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.

The Canadian Press on MSN · 2d

Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

Pfizer withdraws sickle cell drug Oxbryta

Reuters on MSN · 7h

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.

Bloomberg on MSN · 1d

Pfizer’s Sickle Cell Drug Candidates Not Hit by Oxbryta Pull

Investopedia on MSN · 8h

Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns

Key Takeaways Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns.The drug maker said the benefits of Oxbryta no longer outweigh the risks.The company's data indicated patients could suffer from severe pain and even death.

Pharmalittle: We’re reading about Pfizer pulling a sickle cell pill, Moderna getting scolded, and more

The High Court gave a mixed decision in July, ruling that one of Moderna’s two patents relating to the mRNA technology that ...

11hon MSN

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

Judge dismisses family lawsuit against Dept. of Defense after 24-year-old’s “vaccine-related” death

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

1d

Pfizer Is Rising Past Covid-19

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

Time on MSN3d

Is the Novavax COVID-19 Vaccine Better?

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another ...

CNET on MSN5d

What to Know About Novavax, the 'Other' COVID Vaccine

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

2d

Health Canada approves Pfizer-BioNTech's updated COVID-19 vaccine

BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results